Articles From: El Paso Electric Announces Fourth Quarter and Annual Financial Results to Elastichosts Enters Asia-Pacific with Platform Equinix


2013/2/19
El Paso Electric (NYSE:EE) : Overview For the fourth quarter of 2012, EE reported net income of $4.8 million, or $0.12 basic and diluted earnings per share.
Sign-up for El Paso Electric Announces Fourth Quarter and Annual Financial Results investment picks
2013/4/17
El Paso Electric (NYSE:EE) will release first quarter earnings on May 1, 2013.
Sign-up for El Paso Electric First Quarter Earnings Release Date and Conference Call Notification investment picks
2013/2/5
El Paso Electric (NYSE:EE) will release fourth quarter earnings on February 19, 2013.
Sign-up for El Paso Electric Fourth Quarter Earnings Release Date and Conference Call Notification investment picks
2013/4/17
El Paso Pipeline Partners, L.P. (NYSE: EPB) today increased its quarterly cash distribution per common unit to $0.62 ($2.48 annualized) payable on May 15, 2013, to unitholders of record as of April 29, 2013.
Sign-up for El Paso Pipeline Partners Increases Quarterly Distribution to $0.62 Per Unit investment picks
2013/4/18
--Elan accepts tenders for roughly 14.8% of stock outstanding --
Sign-up for Elan $1 Billion Tender Oversubscribed investment picks
2013/4/18
Elan Corp.'s (ELN) modified Dutch auction tender offer for up to $1 billion of stock was oversubscribed and the Irish biotechnology company said it will repurchase about 88.9 million shares at $11.25 a share, the low end of the projected range.
Sign-up for Elan Accepts Tenders for 88.9 Million Shares at $11.25 a Share investment picks
2013/4/2
Elan Corporation, plc (NYSE:ELN) is pleased to announce the closing today of the TYSABRI ® (natalizumab) Collaboration Transaction with Biogen Idec.
Sign-up for Elan Announces Closing of TYSABRI® Collaboration Transaction with Biogen Idec investment picks
2013/2/12
Elan Corporation, plc (NYSE: ELN) today announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2012.
Sign-up for Elan Announces Filing of Annual Report on Form 20-F for Year Ended December 31, 2012 investment picks
2013/4/18
Elan Corporation, plc (NYSE:ELN) (Elan) today announced the final results of its modified Dutch auction Tender Offer, to purchase its Ordinary Shares, including Ordinary Shares represented by American Depositary Shares (Shares), up to a maximum aggregate cost of US$1.0 billion, which closed at 8:00 a.m., Irish time, on April 18, 2013.
Sign-up for Elan Announces Final Results of its Tender Offer investment picks
2013/3/4
The Board of Elan Corporation, plc (NYSE:ELN) (the Company) has approved the decision to initiate a unique cash dividend policy enabling its shareholders to benefit directly from the long term cash flow generated by Tysabri.
Sign-up for Elan Announces Further Unlocking of Value To Benefit Shareholders investment picks
2013/4/25
Elan Corporation, plc (NYSE: ELN) (“Elan” or the “Company”) today publishes the Notice of the 2013 Annual General Meeting of the Company (the “AGM”). The Notice of AGM together with a Form of Proxy has been issued to shareholders.
Sign-up for Elan Announces Publication of Notice of 2013 Annual General Meeting & Directors’ Retirement investment picks
2013/5/15
Elan Corporation, plc (NYSE : ELN) (Elan) today announces publication of a response document in respect of the Echo Pharma Acquisition Limited (Royalty Pharma) offer made on May 2, 2013.
Sign-up for Elan Announces Publication of Response Document investment picks
2013/4/2
Elan Corporation, plc (NYSE:ELN) (the Company) announced today that it has issued an irrevocable Notice of Redemption to redeem all of the $600 million in aggregate principal amount of outstanding 6.25% Senior Notes due 2019 (the “Notes”) of its wholly owned subsidiaries, Elan Finance public limited company and Elan Finance Corp.
Sign-up for Elan Announces Redemption of Its Senior Notes Due 2019 investment picks
2013/2/28
Elan Corporation, plc (NYSE:ELN) today announced the appointment of Mr.
Sign-up for Elan Announces the Appointment of Mr. John Given as General Counsel investment picks
2013/4/10
Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Wednesday, April 24, 2013 at 8:30 a.m. Eastern Time (ET), 1:30 p.m. British Summer Time (BST) with the investment community to discuss Elan’s first quarter 2013 financial results, which will be released before the European and U.S. financial markets open.
Sign-up for Elan Announces Webcast of First Quarter 2013 Financial Results investment picks
2013/4/22
The board of directors of Elan Corp.
Sign-up for Elan Board Rejects Royalty Pharma Takeover Bid investment picks
2013/4/22
Elan Corporation, plc (NYSE: ELN) (Elan) today announced that its Board of Directors, after careful review and consideration and with the assistance of its executive management team as well as outside financial and legal advisors, has determined that privately held investment firm Royalty Pharma's offer, through its shell subsidiary Echo Pharma Acquisition Limited, to acquire all of the shares of Elan for $11.25 or less per share, substantially undervalues the company.
Sign-up for Elan Corporation, plc’s Board of Directors Unanimously Reject Royalty Pharma’s Unsolicited Tender Offer investment picks
2013/3/12
Elan Corporation, plc (NYSE:ELN) (the Company) today disclosed the Tender Offer documentation for the Share Repurchase has been filed and is available on the Company’s website at www.elan.com .
Sign-up for Elan Discloses Filing of Share Repurchase Tender Offer Documentation investment picks
2013/4/12
Elan Corporation, plc (NYSE: ELN) announces that, at an Extraordinary General Meeting (EGM) held earlier today, the sole ordinary resolution to approve the Tender Offer to purchase Ordinary Shares (including Ordinary Shares represented by American Depositary Shares) was overwhelmingly passed with over 99% of the shares voted in favor of the resolution.
Sign-up for Elan EGM Resolution Passed with over 99% Approval investment picks
2013/5/13
Elan Corporation, plc (NYSE: ELN) (Elan) provides additional commentary on today’s royalty participation agreement announcement between Elan and Theravance.
Sign-up for Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement investment picks
2013/3/8
Elan Corporation, plc (NYSE:ELN) (the Company) today provides an update on the Tysabri Restructuring Transaction (“the Tysabri Transaction”) announced on February 6, 2013 and further information regarding the Company’s recently announced proposed $1billion share repurchase program.
Sign-up for Elan Provides Update on Tysabri Transaction and $1bn Share Repurchase investment picks
2013/2/22
Elan Corporation, plc (NYSE:ELN) today provides an update to the market post the February 6, 2013 announcement regarding the restructuring of the Tysabri® collaboration with Biogen Idec.
Sign-up for Elan Provides Update Post Restructuring Announcement of Tysabri Collaboration investment picks
2013/4/24
Elan Corporation, plc today reported its first quarter 2013 financial results.
Sign-up for Elan Reports First Quarter 2013 Financial Results investment picks
2013/5/13
LONDON -- Elan Corp.
Sign-up for Elan Signs $1 Billion Drug Deal investment picks
2013/4/3
The Board of Elan Corporation, plc (NYSE:ELN) (the Company) welcomes this morning's imposition by the Irish Takeover Panel of an expected May 10, 2013 deadline on Royalty Management LLC (Royalty Pharma) (following their original indication of interest announcement of February 25, 2013) by which Royalty Pharma must either announce an offer for Elan under Rule 2.5 of the Irish Takeover Rules or announce that it will not proceed with an offer for Elan.
Sign-up for Elan Welcomes Irish Takeover Panel Statement investment picks
2013/5/13
LONDON --
Sign-up for Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact investment picks
2013/2/25
The Board of Elan Corporation, plc (NYSE:ELN) (the Company) acknowledges this morning's announcement by Royalty Management, LLC (Royalty Pharma) regarding an indicative, conditional, proposal which may or may not lead to an offer being made for the entire issued share capital of the Company.
Sign-up for Elan’s Response to Indication of Interest investment picks
2013/4/15
The Board of Elan Corporation, plc (NYSE : ELN) (Elan) notes this morning’s announcement regarding the offer by Echo Pharma Acquisition Limited (“Royalty Pharma”) to acquire Elan's shares under Rule 2.5 of the Irish Takeover Rules.
Sign-up for Elan’s Response to Royalty Pharma Announcement investment picks
2013/3/6
The Board of Elan Corporation, plc (NYSE:ELN) (the Company) acknowledges this morning's statement by Royalty Management, LLC (Royalty Pharma). Elan’s position remains as outlined on February 25, 2013: Further announcements and business updates by the Company will be made as appropriate.
Sign-up for Elan’s Response to Royalty Pharma Statement of Today investment picks
2013/3/11
Equinix, Inc. (Nasdaq: EQIX ), the global interconnection and data center company, today announced that Elastichosts , a global Cloud Server provider, has deployed in Equinix’s International Business Exchange (IBX®) data center in Hong Kong.
Sign-up for Elastichosts Enters Asia-Pacific with Platform Equinix investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: El Paso Electric Announces Fourth Quarter and Annual Financial Results to Elastichosts Enters Asia-Pacific with Platform Equinix
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity